HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer
about
Interventions for preventing keratinocyte cancer in high-risk groups not receiving immunosuppressive therapyAdvanced basal cell carcinoma, the hedgehog pathway, and treatment options - role of smoothened inhibitorsIdentifying the appropriate comparison group for HIV-infected individualsCutaneous squamous cell cancer (cSCC) risk and the human leukocyte antigen (HLA) system.The risk of non-melanoma skin cancer in HIV-infected patients: new data and meta-analysis.Long-term nitrite inhalant exposure and cancer risk in MSM.Evaluation of surgical margins according to the histological type of basal cell carcinoma.Skin cancer in organ transplant recipients: more than the immune system.Advances in the management of cutaneous squamous cell carcinoma.Knowledge, understanding, and use of preventive strategies against nonmelanoma skin cancer in healthy and immunosuppressed individuals undergoing Mohs surgeryHIV and cancer: a comparative retrospective study of Brazilian and U.S. clinical cohorts.Risk of melanoma in people with HIV/AIDS in the pre- and post-HAART eras: a systematic review and meta-analysis of cohort studies.Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management.Cutaneous manifestations of human immunodeficiency virus: a clinical updateMultiple skin neoplasms in subjects under 40 years of age in Goiania, BrazilPrevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis.Cancer prevention in HIV-infected populations.Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims ("MedWAS").Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this riskNon-AIDS-defining cancers among HIV-infected patients.Optimal management of skin cancer in immunosuppressed patients.Does the nature of residual immune function explain the differential risk of non-melanoma skin cancer development in immunosuppressed organ transplant recipients?Basal cell carcinoma of the skin (part 1): epidemiology, pathology and genetic syndromes.Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load.Spectrum of Immune-Related Conditions Associated with Risk of Keratinocyte Cancers among Elderly Adults in the United States.Risk of skin cancer in multiple myeloma patients: a retrospective cohort study.Frequency of Betapapillomavirus infections among HIV infected and uninfected Black Zimbabweans with cutaneous lesions.Associations of non-melanoma skin cancer and melanoma, extra-cutaneous cancers and smoking in adults: a US population-based study.Updates on the Management of Non-Melanoma Skin Cancer (NMSC).A real-world, community-based cohort study comparing the effectiveness of topical fluoruracil vs. topical imiquimod for the treatment of actinic keratosis.Cancer and HIV infection in referral hospitals from four West African countries.USPSTF Recommendations for Behavioral Counseling for Skin Cancer Prevention: Throwing Shade on UV Radiation.Telomerase promoter mutations in human immunodeficiency virus-related conjunctiva neoplasia.Skin Cancer and Its Treatment: Novel Treatment Approaches with Emphasis on Nanotechnology
P2860
Q26471604-588763E5-0C69-426F-86A1-CB6B1ECF14D9Q26775917-C690BB11-5248-42FF-9473-33972F46DFB9Q27028033-81A527BB-F4C6-496B-A933-D26F07AF5365Q30235983-105CF07B-A506-4C60-BFC2-691921A61BA3Q30956389-84F469FF-497D-498C-ACA2-E785AEAC3A0CQ33631041-F5C1A9E3-950E-4E4A-9D91-DF7FF5A7FED7Q33675780-ACB7F077-6463-4276-94AB-C45A21E6EF7FQ33923227-B7014A9B-4F62-4D62-B7CF-F94864CA2BA6Q34019942-B2940149-C8BF-498F-9E67-9B7DCF707695Q34045147-D5C0A5E6-41A3-44EE-9F86-752BF92690F2Q35083048-F28962F8-7E76-47A1-BB9D-A065D727EF69Q35150769-B608D6A2-96A9-4D48-B45F-6715B39029ADQ35652710-370FF1A3-A4BF-4A19-B62C-D2DDC2312D20Q35660779-2BA2D926-9AD9-4C7D-B65D-5A20DF9AD7DFQ36105088-B2E62681-64CA-470A-921F-FB3DF0C355C5Q36399193-7791F428-03EC-4A9F-BC34-81351BF96AB7Q36680086-4534A8BE-6B1F-4F2E-B473-F5E81D6B6E9DQ37059903-0CA0F941-2A13-4ED6-9E69-5C34F711C800Q37712406-0BDCDA45-454A-4666-A734-88D9651095E6Q38112573-6BCEBA9A-7ED1-4D75-AB68-113FCC51710AQ38228585-E472D7AA-D1CA-4340-B2A0-CF3DBD889D03Q38328785-DEBDF32F-38F4-402F-AAF3-9E7A299EDECCQ38602543-CD92E018-A005-431F-8CAD-BD7592354BABQ40125669-F1605466-3182-4AAC-95F9-2AB8B6B358CBQ40257939-2FB658A9-CF00-4EE4-A732-AA64ABCE7353Q40912690-916386FC-B3A3-4C4F-B6B7-DE8FC0B61E2BQ41682614-A405838F-06D4-4914-820E-7E7AED05728FQ41710151-5795C9ED-7714-438D-BD33-65FA461CED38Q46811811-F39B15BD-BFFD-4BB0-9112-F1505D013896Q48529298-BCCEEA27-BDF0-4C39-8A7A-E3E0310C3555Q50556083-B2C69006-0FB8-4D50-86E6-04F2812007ADQ55105280-91053381-A670-47E4-BCD9-8A0681D98927Q55122468-B60ABFCB-6907-466A-BBFF-648E3AD81787Q57370671-9C515AF4-E01D-4AD8-9CCC-2BC36EE543E2
P2860
HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer
@ast
HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer
@en
type
label
HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer
@ast
HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer
@en
prefLabel
HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer
@ast
HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer
@en
P2093
P2860
P356
P1476
HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer
@en
P2093
Charles P Quesenberry
E Margaret Warton
Eric A Engels
Maryam M Asgari
Michael J Silverberg
Wendy Leyden
P2860
P304
P356
10.1093/JNCI/DJS529
P407
P577
2013-01-04T00:00:00Z